Should You Accumulate Affimed NV (AFMD) Stock Tuesday Morning?

Affimed NV (AFMD) is down Tuesday morning, with the stock decreasing -3.18% in pre-market trading to 6.7. AFMD's short-term technical score of 61 indicates that the stock has traded more bullishly over the last month than 61% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, AFMD ranks higher than 88% of stocks. Affimed NV has risen 1.76% over the past month, closing at $7.07 on November 2. During this period of time, the stock fell as low as $5.65 and as high as $7.35. AFMD has an average analyst recommendation of Strong Buy. The company has an average price target of $12.40.

AFMD has an Overall Score of 60. Find out what this means to you and get the rest of the rankings on AFMD!

See Full AFMD Report

Affimed NV has a Long-Term Technical rank of 48. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 52% of the market scoring higher. In the Biotechnology industry which is number 140 by this metric, AFMD ranks better than 70% of stocks.

Important Dates for Investors in AFMD:

-Affimed NV is set to release earnings on 2/8/2022. During their last earnings release the company posted EPS of $-0.56. -We do not have a set dividend date for Affimed NV at this time. Click Here To Get The Full Report on Affimed NV (AFMD)